Opinion of the High Council for Public Health regarding the mandatory minimum information requirements for advertising the quadrivalent diphtheria-tetanus-polio-pertussis vaccine Repevax®.
Author(s): Haut Conseil de la Santé Publique
Publishing year: 2011
Pages: 131
Weekly Epidemiological Bulletin, 2011, n° 10-11, p. 131
In relation to
Our latest news
news
Call for Nominations for the Renewal of the Scientific Advisory Board of the...
news
Growing Up with Screens. A special report in *La Santé en action* No. 474,...
news
